Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | serdemetan | FIMM | pan-cancer | AAC | 0.053 | 0.7 |
mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.0099 | 0.8 |